Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04709679 · ClinicalTrials.gov registry record · NA
Laser Dosage in MicroPulse TransScleral CycloPhotocoagulation
A NA study, sponsored by State University of New York at Buffalo.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04709679 is a NA study that was terminated before completion, run by State University of New York at Buffalo. The registered enrollment target is 6 participants.
The verdict
NCT04709679, a NA study, was terminated before completion, sponsored by State University of New York at Buffalo.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a prospective study to evaluate the clinical outcome of varying doses of Micropulse TransScleral CycloPhotocoagulation (MP-TSCPC) laser in patients with glaucoma. The study will assess documented complication rates, changes in visual acuity after the procedure, changes in intraocular pressures and medication drop usage, and need for subsequent treatments (including further laser or surgery).
Interventions
- PROCEDURE MicroPulse TransScleral CycloPhotoCoagulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2021-10-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04709679
The ClinicalTrials.gov registry entry for NCT04709679 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MicroPulse TransScleral CycloPhotoCoagulation is the first listed.
NCT04709679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04709679 about?
NCT04709679 is a clinical study titled "Laser Dosage in MicroPulse TransScleral CycloPhotocoagulation". This is a prospective study to evaluate the clinical outcome of varying doses of Micropulse TransScleral CycloPhotocoagulation (MP-TSCPC) laser in patients with glaucoma. The study will assess documented complication rates, changes in visual acuity after the procedure, changes in intraocular pressur...
What is the current status of trial NCT04709679?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-01-01. Estimated completion is 2021-10-11.
What interventions are being tested in trial NCT04709679?
The interventions under investigation include: MicroPulse TransScleral CycloPhotoCoagulation (PROCEDURE).
Who is sponsoring clinical trial NCT04709679?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.